General Electric’s (GE’s) sale of its biopharma unit on February 25 is designed to reduce the company’s overall debt load, and CEO Larry Culp said the deal is the latest…
General Electric’s (GE’s) sale of its biopharma unit on February 25 is designed to reduce the company’s overall debt load, and CEO Larry Culp said the deal is the latest…